Yongke Pharmaceutical

Since its establishment in 2001, Shenzhen Yongke Pharmaceutical Co., Ltd. (hereinafter referred to as "Yongke Pharmaceutical") has been dedicated to the development of the pharmaceutical industry and has gradually grown into a comprehensive pharmaceutical group enterprise integrating research, industry, and trade. Over the past 20 years, Yongke Pharmaceutical has successively established four major business divisions, built a professional academic marketing team, and gradually developed a complete pharmaceutical industry chain. It currently has over 300 employees, more than 200 of whom hold a bachelor's degree or above, accounting for over 70% of the total workforce.
Since its establishment, Yongke Pharmaceutical has been committed to providing high-quality products and services, bringing health and happiness to thousands of households. It has successfully introduced high-quality products from Sweden produced with international patented technology, including "Fibefas," a basic treatment drug for constipation recommended by WGO clinical guidelines. It has independently developed domestic products such as the Yongrui series, health foods, health products, etc., as well as two invention patents—Xianshanqing, a health product for safely resolving constipation in pregnant and postpartum women, and Ruikangneng, a health product that achieves lipid and glucose reduction through dietary regulation. These are all star products that Yongke strives to develop for multiple departments including gastroenterology, proctology, and obstetrics and gynecology.
Yongke Pharmaceutical has established multiple marketing and after-sales service offices in various provinces, cities, and municipalities across China, possessing a strong health product promotion and commercial marketing network. Through professional academic promotion and high-quality products with confirmed efficacy, it has established good communication channels with hospitals and patients.
While continuously developing, Yongke Pharmaceutical places particular emphasis on corporate culture development, striving to create a "home" atmosphere for employees. Every year, it organizes themed cultural activities such as employee outdoor excursions, employee birthday parties, and New Year welcome galas. These not only enrich employees' leisure and cultural life but also enhance the cohesion and solidarity of the enterprise.
In the future, Yongke Pharmaceutical will continue to shoulder its social responsibility and mission, integrate its own resources, focus on strengthening its competitiveness, continuously create value for users, and strive to build Yongke Pharmaceutical into a renowned brand in China's health industry.